{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:13Z","timestamp":1761128533229,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ucl.2005.12.004","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T09:28:46Z","timestamp":1168421326000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radiation Therapy and Radio-nuclides for Palliation of Bone Pain"],"prefix":"10.1016","volume":"33","author":[{"given":"Juanita","family":"Crook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-8140(97)00101-1","article-title":"Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules","volume":"45","author":"Gaze","year":"1997","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib2","first-page":"399","article-title":"External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life","volume":"10","author":"Di Lorenzo","year":"2003","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-8140(98)00011-5","article-title":"Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases","volume":"47","author":"Nielsen","year":"1998","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(97)00952-8","article-title":"The final report of the expert panel for the radiation oncology bone metastasis work group of the American College of Radiology","volume":"40","author":"Rose","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(99)00110-3","article-title":"The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study","volume":"52","author":"Steenland","year":"1999","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2005.12.004_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(97)00927-9","article-title":"Radiotherapeutic management of osseous metastases: a survey of current patterns of care","volume":"40","author":"Ben-Josef","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ucl.2005.12.004_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnci\/dji139","article-title":"Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases","volume":"97","author":"Hartsell","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib8","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/S0360-3016(03)00823-X","article-title":"Phase III radomized trial of 8 Gy in 1 fraction vs. 30 Gy in 10 fractions for palliation of painful bone metastases: preliminary results of RTOG 97\u201314","volume":"57","author":"Hartsell","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0360-3016(02)04147-0","article-title":"Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases","volume":"55","author":"Wu","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ucl.2005.12.004_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(86)80191-8","article-title":"Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases","volume":"6","author":"Price","year":"1986","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","article-title":"The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group","volume":"50","author":"Tong","year":"1982","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0360-3016(98)00264-8","article-title":"Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration","volume":"42","author":"Arcangeli","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ucl.2005.12.004_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/1097-0142(19850401)55:7<1468::AID-CNCR2820550708>3.0.CO;2-M","article-title":"Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis","volume":"55","author":"Blitzer","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party","volume":"52","author":"Yarnold","year":"1999","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jnci\/95.3.222","article-title":"Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial","volume":"95","author":"van den Hout","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ijrobp.2004.05.053","article-title":"Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer","volume":"60","author":"Konski","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0167-8140(00)00238-3","article-title":"Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists","volume":"56","author":"Chow","year":"2000","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00250-4","article-title":"Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review","volume":"56","author":"Roos","year":"2000","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2005.12.004_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2407-4-71","article-title":"Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline","volume":"4","author":"Wu","year":"2004","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0022-5347(17)40897-4","article-title":"Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate","volume":"141","author":"Kuban","year":"1989","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2005.12.004_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0360-3016(01)01495-X","article-title":"Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA)","volume":"50","author":"Salazar","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ucl.2005.12.004_bib22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0360-3016(89)90537-3","article-title":"Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens","volume":"17","author":"Zelefsky","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ucl.2005.12.004_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.bjc.6601158","article-title":"Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases","volume":"89","author":"Liepe","year":"2003","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2005.12.004_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00432-004-0625-0","article-title":"The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain","volume":"131","author":"Liepe","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0302-2838(03)00364-6","article-title":"Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group","volume":"44","author":"Oosterhof","year":"2003","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.ucl.2005.12.004_bib26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s002590050143","article-title":"Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer","volume":"24","author":"Pons","year":"1997","journal-title":"Eur J Nucl Med"},{"issue":"10","key":"10.1016\/j.ucl.2005.12.004_bib27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s002590000315","article-title":"Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement","volume":"27","author":"Kraeber-Bodere","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jama.1995.03530050068035","article-title":"Strontium 89 therapy for the palliation of pain due to osseous metastases","volume":"274","author":"Robinson","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00000421-199604000-00003","article-title":"Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience","volume":"19","author":"Lee","year":"1996","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.coc.0000144728.30492.43","article-title":"Establishing schedules for repeated doses of strontium and for concurrent chemotherapy in hormone-resistant patients with prostate cancer: measurement of blood and urine strontium levels","volume":"28","author":"Ben-Yosef","year":"2005","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0360-3016(93)90309-J","article-title":"Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer","volume":"25","author":"Porter","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ucl.2005.12.004_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0167-8140(94)90411-1","article-title":"A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer","volume":"31","author":"Quilty","year":"1994","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2005.12.004_bib33","first-page":"79","article-title":"Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group","volume":"2","author":"Brundage","year":"1998","journal-title":"Cancer Prev Control"},{"issue":"1","key":"10.1016\/j.ucl.2005.12.004_bib34","first-page":"79","article-title":"Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial","volume":"43","author":"Sciuto","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ucl.2005.12.004_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(00)03639-4","article-title":"Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial","volume":"357","author":"Tu","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ucl.2005.12.004_bib36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.urology.2004.01.034","article-title":"Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer","volume":"63","author":"Sartor","year":"2004","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.ucl.2005.12.004_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00003072-200009000-00009","article-title":"Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain","volume":"25","author":"Menda","year":"2000","journal-title":"Clin Nucl Med"},{"issue":"15","key":"10.1016\/j.ucl.2005.12.004_bib38","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1200\/JCO.2003.12.060","article-title":"Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate","volume":"21","author":"Palmedo","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014305001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014305001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:19:19Z","timestamp":1758806359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014305001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0094014305001229"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2005.12.004","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy and Radio-nuclides for Palliation of Bone Pain","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2005.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}